Skip to main content


SNO Special Interest Tracks

SNO’s special interest Tracks serve to support the Society’s educational and scientific efforts by providing an additional layer of subject matter expertise in the planning of our conferences and events. Specifically, Track chairs are tasked with the following:
  • Submitting concepts for educational sessions to be considered by the Scientific Chairs for invited sessions at the Annual Meeting.
  • Providing content for the Neuro-Oncology Academy.
  • Serving as a subject matter expert resource for the SNO awards committee, scientific planning committee, and officers.
  • Reviewing graded abstracts and shaping one or more concurrent sessions for the annual meeting.
Special Interest Track Chair Co-Leaders
Shawn Hervey-Jumper, Eudocia Lee, Maciej Mrugala

Basic Science: Investigations focused on determining the causal mechanisms of tumors affecting the brain, spinal cord, and peripheral nerves.  
Betty Kim, Jing Wu, Carl Koschmann, Diana Shi, Milan Chheda, Miora Larion

Cancer Neuroscience: Investigations focused on nervous system activity regulation of cancer initiation and growth in addition to mechanisms by which cancer and cancer therapies affect nervous system activity.
Anna Lasorella, David Gutmann, Frank Winkler

Clinical Trials: 
Research studies that test medical, surgical, or behavioral interventions in patients.  
Jason Fangusaro, Jian Campian, Omar Arnaout, Tom Belle Davidson

CNS Metastases: 
Research studies focused on cancer that has spread from a primary solid organ to the central nervous system.  
Michelle Kim, Barbara O'Brien

CNS Rare Tumors: 
Investigations focused on central nervous system tumors with an incidence rate below the threshold defining rare disease.
Shannon Fortin Ensign, Phioanh Leia Nghiemphu

Health Disparities and Social Determinants of Health: Research studies focused on differences in overall health, burden of disease, or health outcomes between populations that are attributable to social, economic, gender, racial, and or environmental factors.
Na Tosha Gatson, Jill Barnholtz-Sloan

Molecular Pathology: 
Research studies involving the use of genomic material to diagnose, classify, and measure the course of disease or response to tumor therapies.
David Solomon, Cristiane Ida, Melike Pekmezci

Neurogenetic Tumor Syndromes: 
Research studies focused on outcomes and/or causal mechanisms of genetic tumor syndromes with associated intracranial neoplasms. 
Angela Hirbe, Rimas Lukas

Investigations focused on hematolymphoid malignancies of the central nervous system.
Joachim Baehring, Lauren Schaff

Neuroimaging Track: 
Research studies focused on structural, metabolic, or functional imaging to assess neoplasms of the central nervous system.
Janine Lupo, Caroline Chung, Christos Davatzikos, Tim Kaufmann

Neurology of Cancer: 
Investigations focused on neurocognitive effects or neurological complications of cancer care.
Nimish Mohile, Andrea Wasilewski

Research studies focused on surgical therapies and drug delivery for brain malignancies.
Garni Barkhoudarian, Linda Bi, Albert Kim

Research studies focused on basic, clinical, and translational sciences for children, adolescence, and young adults with central nervous system malignancies. 
Paul Aridgides, Bradley Gampel, Mohamed Abdelbaki, Kevin Liu

Quality Improvement: Investigations focused on systemic actions that lead to measurable improvements in health care services and health status of targeted patient groups.
Na Tosha Gatson, Jill Barnholtz-Sloan

Radiation Sciences: 
Investigations focused on clinical radiotherapy and radiobiology for the treatment of central nervous system malignancies. 
Jann Sarkaria, David Raleigh, Jona Hattangadi-Gluth

Research studies focused on innovations in patient care, quality of life, palliative care, and end of life for patients with central nervous system malignancies. 
Aaron Yeo, David Cachia, Sabine Mueller